How banks can succeed in 'Save Now, Buy Later'

A new payment method centered around saving is turning the concept of Buy Now, Pay Later on its head.

Wheat prices likely to remain at high levels

Key commercial topics for private banks and wealth managers in 2023

2022 was the end of over a decade long bull run, triggered by Owing to major factors such as supply chain shortages, inflation, the war in Russia’s invasion of Ukraine, the energy crisis, and the continued CovidCOVID-19 pandemic in some regions of the world, 2022 marked the end of a bull run that had lasted over a decade.

Why are sales organizations not excited about price increases?

How healthcare payment solutions can evolve to capture patients’ willingness to pay

More than two years after COVID-19 forced businesses to accelerate their digital strategy, consumers are permanently evolving their payment preferences in favor of digital formats, and businesses are adapting to consumers’ needs.

How to prepare your P&MA function for the future – current challenges and best-practice solutions

Is your P&MA function future ready? The increasing complexity of products, intensified competition, evolution of payers’ needs, and stricter healthcare systems are some of the factors that have increased the need to check in on your P&MA function!

2023 China Medtech Industry Outlook

Building on ongoing in-depth discussions with leaders in the medtech industry, our 2023 China Medtech Outlook is now out, with key themes highlighted in the article.

Frontiers of CGT in China

According to Nature research in 2021, China accounts for over 50 percent of cell therapy trials worldwide. Today, there are around 400 ongoing CAR-T trials in China across a broad range of targets and diverse indications, from hematology/oncology to solid tumors.

China: Commercial health insurance trends

While the National Reimbursement Drug List (NRDL) continues to be the dominant path to public reimbursement in China, commercial health insurance (CHI) in China is quickly emerging as an alternative reimbursement option.

Germany: How the GKV-FinStG law is transforming the pharma P&R landscape

In November 2022, the new GKV Financial Stabilization Act (GKV-FinStG) came into effect after being passed by the German parliament.